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1. Introduction 
Myomectomy is an old reconstructive gynecologic operation intended to preserve a 
functioning uterus suitable for a possible subsequent pregnancy. A lot of the published 
work on endoscopic myomectomy demonstrates the feasibility of the procedure, highlights 
the possible advantages, and expresses the skills of the surgeons (1). The question now is not 
whether the procedure is feasible endoscopically, but whether the endoscopic approach is 
superior and beneficial to a particular patient as well as cost effective for the community at 
large (2). Modern practice should be focused on evidence-based medicine (EBM) concept (3). 
2. Principles of reconstructive surgery 
Reconstructive surgery aims to put genital organs and tissues back together in a way that 
makes them more functional, and /or with fewer clinical symptoms. It leads to reduce 
potential problems and side effects from primary surgery and improve patients' quality of 
life. Early discharge within 24 hours after the procedure with an excellent outcome is a 
common sequel to reconstructive gynaecologic surgery even if done via laparotomy (2). 
Nevertheless, reconstructive surgery requires high level of expertise, delicate instruments, 
fine maneuvers, longer time, and fine energy modalities.   
3. Fertility-preserving reconstructive gynecologic surgery 
If future fertility is of concern, endoscopic reconstructive gnecologic surgery should follow 
microsurgical principles (4,5) which include avoidance of serosal insults e.g. tissue trauma, 
ischemia, hemorrhage, infection, foreign-body reaction, and leaving raw surfaces (6). Other 
microsurgical principles include minimizing tissue trauma by using atraumatic techniques, 
meticulous hemostasis, complete excision of abnormal tissues and precise alignment and 
approximation of tissue planes (7). With this so meticulous reconstruction of the 
gynecological structures, maximal possibilities of pregnancy without the utilization of other 
complex procedures of assisted reproduction can be achieved. It has been estimated by some 
enthusiastic proponents that microsurgery could results in double the pregnancy rate 
compared conventional macrosurgery (8). However, a recent Cochrane review did not 
demonstrate any advantage of microsurgery over the conventional approach (6). 
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Laparoscopic microsurgeons should have enough experience in classical microsurgery as 
well as highly-developed two-handed laparoscopic skills for intracorporeal knotting (9,10).  
4. Reconstructive laparoscopic myomectomy (LM) 
The first LM is performed in 1980 when several pedunculated subserous fibroids are 
removed laparoscopically (11). Since then, several descriptive series (12,13) on LM have 
been published and these have highlighted several problems associated with the procedure. 
Long operating times have been reported with some exceeding seven hours (14). This may 
be related to the need to morcellate the fibroids to facilitate their removal as well as the need 
for laparoscopic suturing which can be tedious (15). Increased adhesion formation has also 
been described following this procedure (16). Furthermore, several authors (17-19) have also 
reported cases of uterine rupture/dehiscence following LM.  More attention should be paid 
to careful uterine repair following this laparoscopic procedure. A large series of pregnancies 
after LM (20) reported on 100 patients who eventually had deliveries, and recorded only one 
uterine rupture occurred at the site of the old LM scar (1%; 95% CI, 0.0–5.5%). Although the 
authors concluded that spontaneous uterine rupture seems to be rare after LM, they caution 
and re-iterate that particular care must still be given to uterine closure. Data on the risk of 
recurrence after LM has been published (21) in a series of 622 patients monitored with 
ultrasonography. They reported a cumulative 10 year recurrence rate of 27%.  Although 
several authors (13,22) have reported pregnancies after LM, there are still no long term data 
on subsequent fertility following the procedure. Mais et al (23) conducted a prospective RCT 
comparing early postoperative outcome following LM and laparotomy in 40 patients. They 
reported less postoperative pain, a shorter hospital stay and a faster rate of recovery after 
laparoscopy as compared to open surgery. Several authors (11-14,21) have suggested that 
laparotomy may be preferable to the laparoscopic approach in patients with large multiple 
myomas, especially in the presence of severe endometriosis. In general, LM is associated 
with a shorter hospital stay, faster recovery and less blood loss that could be explained in 
part by the tamponade effect of the pnuemoperitoneum.  Patient satisfaction with operative 
scar after LM is good (24) and as well as fertility satisfaction and reproductive outcome (23).    
4.1 Patient selection 
Indications include infertility, recent and significant uterine enlargement and symptoms like 
pelvic pain, pressure, menometrorrhagia and abnormal bleeding (25).  Inclusion criteria 
include age ≤42 years, the presence of at least one symptomatic myoma >3 cm, and a 
number of myomas equal or less than seven (26). Some authors (27, 28)  suggested that no 
more than three or four myomas with diameters <7–8 cm are to be removed; Nevertheless, 
the decision should be individualized according to the surgical skills, facilities, age and the 
pathologic findings (29,30).   
4.2 Role of LM in infertility 
Whether to perform LM or open microsurgical minilaprotomic myomectomy is a 
controversial issue. Added to the well documented advantages of laparoscopy, LM  is 
associated with fewer postoperative complications and since no preoperative or 
intraoperative factors seem to influence the fertility outcome in women with uterine 
myomas, it is considered as the treatment of choice in infertile patients (31). Those infertile 
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cases with myomata are mostly hyperestrogenic; so laparoscopy will help treat associated 
lesions particularly endometriosis. 
4.3 Preoperative preparation 
You should get a consent for either LM or emergency laparotomy whenever required if 
technical problems or excessive bleeding would be encountered. The size, number, and 
location of the fibroids as well as the experience of the surgeon all must be factors in the 
decision to proceed with the laparoscopic approach. Although several suggestions have been 
made, opinions differ.  Whether to use preoperative hormonal preparation or not is still a 
controversial issue. Some studies reported on significant reduction of the myoma size and 
introperative blood loss on gonadotrophin-releasing hormone agonist or antagonist.   Zullo et 
al (32)  noted that preoperative use of leuprolide acetate decreased estimated blood loss from 
172 mL to 132 mL and operating time from 113 minutes to 99 minutes. Felberbaum et al (33) 
reported on significant preoperative reduction of uterine fibroids in only 16 days by 
administration of a gonadotrophin-releasing hormone antagonist (Cetrotide).  On the other 
hand, longer operative times, 112 minutes versus 157 minutes, with preoperative GnRH 
analog use found by Campo and Garcia, are attributed to difficulty in detecting the myoma 
cleavage plane (34). My practice for a long time is to give patients medorxyprogesterone 
acetate 15 mg daily for 20 days prior to LM and I notice good surgical field in most of cases.  
4.4 Operative technique 
LM is usually performed with a standard technique using three suprapubic ports. The 
uterus is always cannulated to allow the correct exposure of myomas. For pedunculated 
myomas, the pedicle are secured using a pre-tied or extracorporeally-tied loop and 
coagulated and transected with bipolar forceps and scissors. For subserous and intramural 
myomas, serosal incision should be made vertically over the convex surface of the myoma 
using a monopolar hook, fine needle or one blade of a scissors (Figure 1). 
 
 
Fig. 1. Uterine incision. 
After exposure of the myoma pseudocapsule, grasping forceps is positioned to apply 
traction to the myoma and expose the cleavage plane (figure 2). An option is to use a 10 mm  
myoma driller from a midline incision to hold and grasp the myoma firmly against the 
anterior abdominal wall to facilitate enucleation.   Enucleation is carried out by traction on 
the fibroid and by division with a unipolar hook or needle or mechanical cleavage.  
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Fig. 2. Myoma enucleation. 
Hemostasis during dissection is achieved by bipolar  or spray monopolar coagulation. 
Suturing is usually done along one or two layers including the serosa depending on the depth 
of incision with interrupted, simple or more frequently cross-stitches tied intracorporeally 
using 1 or 0 Polyglactin sutures or any delayed absorbable sutures (figure 3).  
 
 
Fig. 3. Closure of the uterine defect with sutures. 
A recent study (35) evaluated the use of bidirectional barbed suture and found it 
significantly shortens the mean duration of surgery. 
Morcellation of the myoma is followed by irrigation and placement of adhesion barrier. As a 
trial to reduce bleeding during LM, Zhao et al (36) tested  loop ligation of larger myoma 
pseudocapsule combined with vasopressin before LM and found it very effective in 
minimizing bleeding in a randomized controlled trial.  
Removal of the fibroids can be performed using morcellation (figure 4), minilaparotomy, or 
colpotomy  Alternatives to these are to destroy the fibroids in place with cryotherapy, 
bipolar cautery, or laser. No trials have compared these techniques to determine which is 
the safest or most effective. Chen et al (37) tried simultaneous enucleation and in situ 
morcellation of myoma and found it convenient.  Don’t forget to leave an intraperitoneal 
drain for few hours via an auxillary portal. 
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Fig. 4. Morcellation of the myoma. 
4.5 Disadvantages of LM 
Although LM has been shown to be feasible, the technique is fraught with problems. 
Furthermore, its place in the treatment of infertile patients still needs to be defined. 
Laproscopic closure of the uterine incision is performed in a rather simplified manner 
utilizing just few stitches, unlike conventional open myomectomy. There is a need for 
meticulously studying the healing pattern of the uterine incision following LM.  Integrity 
of uterine scar is an important consideration for women desiring pregnancy. LM is 
accused to be a procedure that leaves behind insecure uterine scars as evidenced by 
reported cases of uterine rupture following LM. Although uterine ruptures during 
pregnancy have been reported after myomectomies via laparotomy, these are usually 
sporadic reports (14,15,17, 38-40).   Risk factors for uterine rupture after LM may be 
intramural haematoma formation at the incision site, tissue necrosis because of thermal 
damage leading to defective scar formation, or incorrect approximation of incision edges 
leading to healing by secondary intention.  Uterine rupture and fistula formation after LM 
have been reported (14,15,17, 40-42).  However, none of these investigators closed the 
uterine defect in layers.  In another series (43), no case of uterine rupture has been 
reported following pregnancies after LM.  The authors have emphasized the importance 
of avoiding excessive thermal damage and of adequate uterine repair using multiple layer 
suturing techniques. In cases of deeply embedded myomas, larger than six to seven 
centimetres in size, LM may be replaced with laparoscopic assisted myomectomy (44). 
Suturing the myometrium in layers during a LM is also necessary to prevent iatrogenic 
adenomyosis (45).   
4.6 Postoperative care 
Like any laparoscopic surgery, LM cases should be monitored. Care of the amount of blood 
loss in the drainage set. Better to prescribe antibiotics and antipyretics whenever required. 
Instruct you patient to avoid vagina manipulations or douches if posterior colpotomy is 
performed. Moreover, she has to avoid sexual intercourse for at least 4 weeks if colostomy is 
performed. I don’t recommend advising pills for contraception as those cases are usually 
infertile. She has to use a local method for 1-2 months only. 
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4.7 Follow-up 
Our school since 1992 is to follow up cases by both transabdominal and transvaginal 
ultrasonography to properly evaluate healing of the scar till complete disappearance of the 
signs of healing. 
4.8 Assessment of the integrity of the uterine scar following LM 
Various modalities to assess scar healing and strength in the postoperative period have been 
suggested (46). Ultrasonography is used to detect haematoma formation in the uterine scar. 
Doppler studies can be used to assess the uterine scar, possibly recognizing the irregularities 
in the vascular patterns and haematoma formation, which depict poor quality uterine scar.  
Velocimetric findings at 30th postoperative day may be able to assess the healing process.  A 
high resistance index may suggest abnormal healing and an area of fibrosis (47,48).  
Hysterosalpingography, despite being non-specific, may be performed to detect the 
presence of any fistulae (15).  Second-look laparoscopy may be carried out between four to 
eight weeks postoperatively and a methylene blue test is performed to check any uterine 
fistula.  The place of second look laparoscopy has been particularly emphasized in relation 
to assessment of any postoperative adhesions and its treatment (48,49).  
4.9 Impact on reproductive health 
Again, those cases are usually hyperestrogenic with evidence of adenomyosis uteri, 
endometrial htperplasia or endometriosis. So, laparoscopy allows proper assessment of 
those infertile cases. If an office hysteroscopy is performed prior to LM, this would be 
considered as one of the keys of success regarding future fertility. Therefore, LM would help 
solve the infertility problem of those cases. Adding the advantages of laparoscopic surgery 
with definite lower risk of adhesion formation if compared to laparotomy would favor LM. 
4.10 LM versus conventional myomectomy 
There is no difference in fertility efficacy outcome if fibroids are removed via laparotomy 
when compared to laparoscopy (50). Because hematoma formation of measurable size is not 
normal in wound healing, subsequent uterine rupture may be related to poor wound 
healing in the presence of hematoma (51).  We studied 22 cases that are treated with LM 
followed by suturing of the incision in two or three layers trying to mimic open 
myomectomy (52). Moreover, we studied 169 cases treated with conventional open 
myomectomy with meticulous closure of the incision in multilayers (53). Laparotomy study 
(53) included many cases with multiple myomata (mean number is 2±0.4) and of varying 
size (mean size is 216 cm3±61 cm3). Paradoxically, despite having myomata of smaller size 
with less mean numbers, the laparoscopy study (52) demonstrated higher percentage of 
hematoma formation in the early postoperative period (74% versus 24% for laparoscopy and 
laparotomy studies respectively). This highlights the superiority of open microsurgery in 
terms of meticulous suturing simply because it is technically more feasible than laparoscopic 
suturing.  Continuous training of endoscopists on improving suturing techniques and 
innovation of easier suturing devices would facilitate thorough laparoscopic multilayer 
suturing of the myomectomy scar. Nevertheless, the impact of the early postoperative 
hematoma on wound healing is not clear so far.  At 4-6 weeks postoperatively, the incidence 
of hematoma formation in both studies (52,53) declined markedly (8% at 6 weeks versus 7% 
at 4 weeks for laparoscopy and laparotomy studies respectively). Thus, the procedure 
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should involve multilayered uterine closure to avoid hematoma formation, weaker scar and 
subsequent rupture.  However, the only way to answer the question as to whether LM can 
ensure a safe obstetric outcome as open myomectomy, is to perform a large multicenteric 
comparative trial.   LM  offers  significantly less febrile morbidity, lower transfusion rates, 
and shorter hospitalization stays if compared to open myomectomy  (54). Moreover, it 
results  in shorter operative times and lower postoperative hemoglobin, while hospital stay 
and pain are less in the laparoscopic group if compared to laparotomic approach (55). 
5. Reconstructive hysteroscopic myomectomy (HM) 
Submucous myoma may cause abnormal vaginal bleeding, pain, &/or infertility. The 
incidence of myoma in women with otherwise unexplained infertility is estimated to be 1.0–
2.4% (56,57). A systematic review of 11 cohort studies suggests that women with submucous 
myoma have lower pregnancy rates compared with women with other causes for their 
infertility (RR 0.30, 95% CI 0.13 to 0.70).  HM is not associated with an increase in live birth 
rate (RR 0.98, 95% CI 0.45 to 2.41) but is associated with a higher pregnancy rate (RR 1.72, 
95% CI 1.13 to 2.58) (58). Both HM  and polypectomy appeared to enhance fertility 
compared with infertile women with normal cavities in one study (59). HM currently 
represents the standard minimally invasive surgical procedure for treating submucous 
fibroids, with abnormal uterine bleeding and reproductive issues being the most common 
indications (60,61). Nevertheless, this technique is associated with significant risks of 
excessive bleeding, prolonged operative time required for cutting the myoma into chips of  
tissues and extractiing them, risks of fluid overload,  and the possibility of incomplete 
resection  and  perforation (62). To reduce these risks, more effective patient selection and 
improved techniques are necessary (63).  
5.1 Indications of HM 
It is well established and settled that all evidence consider HM as the gold standard and 
nearly the only line of therapy of submucous myomata of suitable size. The problem is the 
definition of “suitable size”. Most centers consider 2-4 cm as an optimal size. If larger 
myoma is diagnosed, HM can be tried either on 2 session bases or utilizing our modified 
technique (see below). An important issue is the association of adenomyosis or intramural 
myomata. You can excise more than one myoma on the same setting provided the general 
condition of the patient can tolerate. 
5.2 Preoperative preparation of HM 
Patient selection is essential to achieve resolution of bleeding symptoms, enhance fertility, 
and reduce surgical risks. Preoperative imaging with MRI, 3-dimensional ultrasonography 
or saline-infused sonohysterography (SIS) can provide a map of the uterine myomas and 
identify the intramural component of the fibroids. The European Society of Hysteroscopy 
designed a classification system for submucosal fibroids based primarily on this concept (64, 
figure 5). 
 Type 0 fibroids are pedunculated with no intramural component. 
 Type I fibroids are sessile submucosal fibroids with less than 50% intramural 
component. 
 Type II fibroids have a greater than 50% myometrial invasion. 
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                    Type 0                                       Type 1                                      Type 2 
Fig. 5. Classification of submucous myomata. 
Incomplete resection of the fibroid is more likely in type II fibroids with more extensive 
intramural component. Calculated from one study is a 50% chance per procedure of 
complete resection of type II fibroids, 60% of type I fibroids, and 92% of type 0. After an 
incomplete resection, the residual intramural component is likely to be expelled into the 
cavity and a second procedure is often successful. The patient with type II fibroids should 
be counseled on the risk of failure and the procedure should be performed by experienced 
hysteroscopic surgeons (65). 
Preoperative hormonal preparation of the myoma is a controversial issue. HM should be 
performed essentially postmenstrual.   Preoperative cervical ripening with a prostaglandin 
analogue has been demonstrated to facilitate cervical dilation.  In a controlled randomized 
study (66), we succeeded to prove that Misoprostol 200 mcg applied vaginally 8-12 hours 
prior to surgery is well tolerated and can decrease surgical time and reduce the risk of 
surgical complications.  
5.3 Techniques of HM 
Myoma resection is usually performed with a loop electrode (figure 6) by shaving the 
visible portion of the myoma into small pieces. Sometimes, myomas deeply embedded in 
the myometrium cannot be completely excised. Other techniques for removing the 
myoma hysteroscopically include using an Nd:YAG laser fiberor electric myoma 
vaporizer (65). 
Various sizes of operating hysteroscopes are now available, but they all include a telescope 
with a fiberoptic light source and camera. The angle of the telescope is either 0º or an acute 
angle of 12-30º. The straight visual 0º scope might be helpful with fundal myomas but an 
angled perspective is more commonly used for fibroid resection. The telescope inserts 
through an external sheath and internal sheath for continuous outflow and inflow of 
distension media.  The working element of the operating hysteroscope is the resecting loop 
that is available in many sizes and angles. The electrosurgical energy connected to the loop 
can be monopolar or bipolar. With the monopolar loops, using nonionic distension media 
such as glycene 5% or sorbitol 1.5% is necessary. With bipolar loops, both electrodes are 
within the cavity and normal saline can be used for distending solution. For hysteroscopic 
myomectomy, various laser types and mechanical loops without electrical energy have also 
been described (65). 
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Fig. 6. Myoma cutting with the resectoscope. 
There are multiple methods of using the electrosurgical loop to optimize fibroid resection 
(figure 7). To maintain good visualization, fragments of resected fibroid need to be removed 
during the procedure. The surgeon may transfer fragments out of the field of resection or 
retrieve them from the cavity by grasping the tissue with the resecting loop. An intrauterine 
morcellator has recently been introduced that may improve surgical time by aspirating 
fibroid fragments through the hysteroscope (65).  When applying the monopolar loop, 
currents as high as 75-150 W are required for smooth tissue cutting. Current should only be 
applied while the loop is being retracted into the hysteroscope or while the entire 
resectoscope is being pulled away from the fundus. A combination of the 2 movements is 
used by the surgeon to safely and effectively slice through the tissue. 
 
 
Fig. 6. Resectoscopic myomectomy. 
Resection of type 0 fibroids can be accomplished in 1 step by most hysteroscopic surgeons 
since the border of the fibroid with the endometrium is easily identified (67).  Type I and 
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type II fibroids require more surgical expertise as resection of the fibroid extends into the 
myometrial space. Intraoperative cervical injection of carboprost, a methyl analogue of 
prostaglandin F2-alpha, has been shown to cause uterine contractions and thereby squeeze 
the remaining fibroid into the cavity to facilitate a single step. Concomitantly performing 
laparoscopy with intramuscular injection of prostaglandin F2-alpha is also effective for 
resection of large fundal fibroids and provides transabdominal visualization (68). In many 
circumstances, resection of large fibroids with significant intramural component is a 2-step 
approach since there is often further intracavitary expulsion of the fibroid after the initial 
surgery. The second procedure can be performed 3-6 weeks later when the residual fibroid 
has migrated into the submucosal space (69).  
5.4 Modified HM for big or intramural myomas: Darwish’s technique (70) 
All cases should be subjected to office hysteroscopy in the immediate postmenstrual period 
not preceded by hormonal priming.  The objectives are to confirm the sonographic diagnosis 
of myoma, comment on the number and the size, assess the site of the myoma in relation to the 
tubal ostia and the uterine walls, detect any pedicle and to estimate the depth of the myoma in 
relation to the uterine wall.  If more than half of the myoma protrudes into the endometrial 
cavity, the case will be considered a submucous myoma.  If the intramural part is more than 
the intracavitary part, the case will be considered an intramural myoma (type II). 
Modified resectoscopic technique starts 8 hours prior to the time of surgery by inserting  200 
µg misoprostol intravaginally to allow softening of the cervical canal and the myoma itself.  
The   resectoscope is  used to make a deep circumferential incision all around the base of the 
myoma (figure 7) until complete separation occurs and the myoma became completely free 
inside the endometrial cavity.  
 
 
Fig. 7. Circumferential incicion. 
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This crucial step required changing the angle of the loop electrode into 15 degrees below the 
horizontal plane to allow easy access to the base. Cutting is made 3-4 mm from the base 
towards the myoma side to preserve some healthy endometrium for postoperative creeping 
to cover the row area of the myoma.  A specially designed 2 mm myoma driller simulating 
the laparoscopic myoma driller is introduced alongside the resectoscope under vision. It is a 
stainless steel wire with a terminal screw.  This driller (figure 8)  is used to tract the myoma 
at one side of the endometrial cavity to have an easy access to the base.    
 
 
Fig. 8. Hysteroscopic myoma driller 
This step is followed by extraction of the whole myoma through the primed cervical canal 
using a ring forceps.  If some difficulty is encountered, the myoma is longitudinally bisected 
into 2 parts using resectoscopic knife electrode prior to extraction. 
If an intramural extension is diagnosed, the following additional steps are done.  A vertical 
linear incision is made over the whole length of the myoma to allow bulging of the myoma 
into the endometrial cavity i.e. to become a more submucous myoma like opening of the 
capsule at open myomectomy.   IV injection of diluted 0.25 mg ergometrine is given by the 
anesthiologist to promote uterine contraction in this non-pregnant uterus and to reduce the 
vascularity.  Moreover, minimization of the intrauterine pressure is done to allow most of 
the myoma to become intracavitary "Myoma shift" as previously described.  The base of the 
myoma is circumfrentially cut with resectoscope using the former mechanical technique.  
 
 
Fig. 9. Postmyomectomy tissue assessment. 
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The resectoscope is reinserted after extraction of the myoma to ensure complete excision.  
Operative hysteroscopy is performed using continuous-flow resectoscope after cervical 
dilatation up to Hegar’s 10 utilizing 1.5% glycine as a distending medium. Operative notes 
should include comment on the feasibility of the operation, operating time calculated from 
the starting myomectomy until complete extraction of all tissues from the endometrial 
cavity, amount of fluid used for distending the uterine cavity, possible intraoperative or 
postoperative complications, and the amount of postoperative blood loss estimated by 
insertion of an intrauterine balloon at the end of the procedure.  All the extracted tissues are 
evaluated (figure 9).  Prophylactic antibiotics are prescribed for all cases. 
5.5 Postoperative care 
No need for hormonal treatment at all. Sometimes, an intrauterine balloon is left inside the 
endometrial cavity to control excessive bleeding from the bed of the myoma.  
5.6 Limitations of reconstructive HM 
It is  the most dangerous hysteroscopic procedure due to possible excessive bleeding, 
prolonged time consumed for cutting the myoma  into chips of  tissues and their extraction 
outside the uterine cavity, the risks of fluid overload, possibility of incomplete resection, 
and liability to perforation. (71). Moreover, there are some studies concerned with the risk of 
uterine rupture in the subsequent pregnancy (72,73).  Most of complications of HM are 
encountered with large sized myomas, or those with intramural extension (grade 1 or 2 
according to the European Society of Hysteroscopy classification). They represent definite 
nightmare for hysteroscopists even with sufficient experience to the extent that some studies 
preferred laparoscopic approach in such cases (74).  Hysteroscopically, several studies tried 
to facilitate one-step complete excision.  In a case report, succeeful removal of myoma up to 
12 cm in one session is reported (75).  A modified hysteroscopic approach for big myoma 
with or without intramural extension has been introduced by our team (70).This technique 
has been cited and quoted in subsequent publications (76) and comprehensive review 
articles (77) on this topic. It comprised combined resectoscopic and mechanical approaches 
to enucleate the myoma in a shorter time with minimal complication rate if compared to the 
standard morcellation technique. Moreover, it demonstrated some additive perioperative 
steps that facilitated the procedure like preoperative usage of misoprostol based on a RCT 
done by our team (66), intraoperative slow IV ergometrine administration, utilization of a 
novel hysteroscopic myoma driller, and performing a vertical incision on top of deeply 
impacted intramural myomata. If compared to a study on 44 cases published in the same 
year (78), the difference would be clear. They performed only circumferential incision at the 
level of myoma base followed by morcellation technique. They succeeded to perform this 
procedure in 41 (93. 1%) of 44 women. Of these, 38 (92.6%) had myomas between 2 and 4 cm 
in diameter and 3 (7.4%) had myomas exceeding 4 cm. Mean operating time is 27 minutes 
(range 10-45 min). It seems very risky to perform morcellation of a big myoma with high 
possibility of fluid overload that would obligate the hysteroscopist to stop the procedure 
based on the recommendation of the anaesthesia team. As a trial to alleviate this risk, one 
case report is recently published utilizing our previously recommended basal 
circumferential incision followed by central vaporization, and intraoperative injection of 
prostaglandin F2alpha (76). Likewise, laser HM guided by laparoscopically assisted intra-
abdominal sonohysterography (LHMY-GLAIS) is described in a preliminary study (79). 
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All these trials would be expected to open the door for more ideas on HM for myomata of 
considerable size. In this context, innovation of alternative hysteroscopically-guided devices 
would be promising. Moreover, studies on bipolar resectoscopic myomectomy utilizing 
saline 0.9% should be encouraged.  
5.7 Complications of HM (65) 
Complications of hysteroscopic myoma resection include hemorrhage, uterine perforation, 
damage to the cervix, and excessive absorption of the distention media (usually glycine) into 
the vascular system, which can cause metabolic disturbances.  The most serious potential 
complication with hysteroscopic myomectomy is excessive absorption of distension media, 
which can cause pulmonary edema, hyponatremia, cerebral edema, and even death. This is 
especially true when using nonconducting distension solution with monopolar cautery. A 
surgeon should also be cautious with saline during resections with bipolar cautery since 
large volumes of fluid can lead to overload complications. A fluid management system that 
can accurately calculate the amount of absorbed fluid by measuring the inflow and outflow 
of distension fluid should be used. Intracervical injection of dilute vasopressin, in addition 
to reducing the force needed to dilate the cervix, has also been shown to decrease the 
absorption of distention fluid.     In 1991, Corson and Brooks noted 1 case of heavy bleeding 
that required transfusion and 3 uterine perforations out of 92 patients undergoing 
hysteroscopic myoma resection.   In 1993, Indman noted distension media complications in 2 
of 51 women. Intrauterine synechiae can also occur after hysteroscopic myoma resection.  
5.8 Impact on the reproductive health 
Many studies have assessed fertility rates after hysteroscopic myomectomy and have noted 
pregnancy rates similar to those after abdominal myomectomy, approximately 60% Again, 
no studies include expectantly managed control groups (65). 
5.9 Poorly evidenced endoscopic myomectomy 
Laparoscopically-assisted transvaginal myomectomy has been described for posterior and 
fundal myomas where a posterior colpotomy is done to allow delivery of myomata and the 
uterus as well. Uterine reconstruction is then performed by conventional suturing 
performed transvaginally. The uterus is then replaced into its anatomical position and 
colpotomy is repaired. A final laparoscopic survey and lavage is performed (80,81).  
Colposcopic myomectomy is first described by Baggish in 1990s. Thereafter, two case 
reports with cervical fibroids underwent laser CO2 excision under colposcopic guidance 
(82). 
5.10 Endoscopic myomectomy prior to IVF/ICSI 
The impact of uterine myoma on the outcome of IVF/ICSI is a very controversial topic. 
Many centers are overdoing myomectomy for nearly all myomata regardless size and site 
considerations. Contrary, other investigators have shown that fibroids don't exert a 
deleterious effect. Nevertheless, many studies have provided evidence that uterine myomas 
have a significant effect on IVF outcomes and there is a large body of evidence that 
treatment of uterine myomas increases fertility and pregnancy rates, and decreases the rate 
of pregnancy loss (83). There is no doubt that any cavity-distorting myoma should be 
removed whether completely submucous or interstitial myoma with submucous 
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encroachment. This highlights the central role of prior hysteroscopy as well as saline 
infusion solonhysterography (SIS) as previously described (84). Controversy exists for 
interstitial and subserous myomata. The evidence supports treatment of all very large 
myomas (>7 cm) (83). Subserosal myomas that are smaller than 7 cm in size and intramural 
myomas of less than 4–5 cm in diameter appear to have little effect on IVF outcomes.  Larger 
intramural and subserosal myomas present a clinical dilemma and more studies are needed 
to clarify a definitive plan for management (83).  In a prospective controlled study, the 
distance between the intramural myomas and the endometrial lining did not appear to 
affect the IVF outcome. An insignificant tendency towards improvement of IVF outcome is 
found in myomas at more than 5 mm from endometrial lining (85).  
6. Keynote points 
Uterine myoma may affect fertility according to its size, site and associated pathology. 
Endoscopic approach has a definite role in its management.  HM is the gold standard line of 
management of submucous myoma of suitable size. LM doesn't seem to be superior to 
conventional open myomectomy regarding fertility and is characterized by both short and 
long term drawbacks. Uterine myomata would affect IVF/ICSI outcome whenever 
disturbing the endometrial cavity or large sized. The impact of other types of myomata on 
IVF/ICSI deserves further studies. 
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